Digital Therapeutics Market Growth Accelerated by Increased Adoption of Prescription Digital Therapeutics
Digital therapeutics deliver evidence-based therapeutic
interventions to patients that are driven by high quality software programs to
prevent, manage, or treat a medical condition. They are utilized independently
or in conjunction with drugs and devices and are designed to act on patients
through software applications and software-based therapeutic interventions.
Digital therapeutics help managing conditions like chronic disease,
neurological disorders, substance use disorders in a more efficient way
compared to traditional treatment options. The global Digital
Therapeutics Market is estimated to be valued at US$ 6.6 Bn in 2023 and is
expected to exhibit a CAGR of 20% over the forecast period 2023 to 2030, as
highlighted in a new report published by Coherent Market Insights.
Market key trends:
The growing adoption of prescription digital therapeutics by various healthcare
providers as well as patients has been a major factor fueling the growth of
this market over the forecast period. Digital therapeutics have been proven to
be an effective solution to deliver evidence-based treatment of medical
conditions and encourage positive health outcomes. For example, prescription
digital therapeutics have shown promising results in conditions like diabetes,
hypertension, mental health disorders, and others. The high affordability and
accessibility of digital therapeutics compared to traditional healthcare
options have further boosted their adoption rates globally. Rising investments by
startup companies as well as large enterprises in developing innovative digital
therapeutics and clinical validations have positively impacted the market
growth trends.
Segment Analysis
The global digital therapeutics market is dominated by lifestyle management
applications that aim to prevent and manage lifestyle-related chronic diseases
like diabetes, hypertension, and obesity. Lifestyle management applications
held a dominant share of over 40% in the market in 2022 due to the rising
prevalence of chronic lifestyle diseases that require continuous monitoring and
therapeutic interventions.
Key Takeaways
The global digital therapeutics market is expected to witness high growth over
the forecast period of 2023 to 2030. Regional analysis
North America currently dominates the global digital therapeutics market owing
to the presence of favorable government initiatives and regulations related to
digital health in countries like the US. Moreover, high healthcare expenditure
and growing awareness about digital therapeutics among patients and healthcare
providers also contribute to North America's large share. However, Asia Pacific
is expected to be the fastest growing regional market during the forecast
period due to the rising geriatric population, growing incidence of chronic
diseases, and increasing investments by market players in emerging countries of
the region.
Key players operating in the digital therapeutics
market are Happify, Inc., 2Morrow, Inc., Akili Interactive Labs, Inc., Click
Therapeutics, Inc., and Fitbit, Inc. (Twine Health, Inc.). Happify offers a
digital platform of therapeutic applications for Stress, Depression and
Anxiety. 2Morrow provides digital therapeutics for type 2 diabetes treatment
and management. Akili Interactive focuses on digital treatments for mental
health disorders like ADHD using behavioral video games.

Comments
Post a Comment